$777 Million is the total value of Meditor Group Ltd's 8 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALKS | ALKERMES PLC | $56,407,000 | +7.7% | 1,030,639 | 0.0% | 7.26% | -8.7% | |
CLDX | CELLDEX THERAPEUTICS | $17,928,000 | -0.7% | 6,312,700 | 0.0% | 2.31% | -15.8% | |
SPXU | PROSHARES ULTRAPRO SHORT S&P500 | $13,985,000 | -17.6% | 1,230,000 | 0.0% | 1.80% | -30.1% | |
SDS | PROSHARES ULTRASHORT S&P500 | $12,931,000 | -12.0% | 315,000 | 0.0% | 1.66% | -25.4% | |
EPI | WISDOMTREE INDIA EARNINGS FUND | $11,136,000 | +10.6% | 400,000 | 0.0% | 1.43% | -6.2% | |
INDA | ISHARES MSCI INDIA ETF | $10,460,000 | +9.8% | 290,000 | 0.0% | 1.35% | -6.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EXELIXIS INC | 43 | Q4 2023 | 88.9% |
ALKERMES PLC | 31 | Q4 2020 | 62.6% |
ISHARES MSCI INDIA ETF | 31 | Q4 2023 | 5.5% |
WISDOMTREE INDIA EARNINGS FUND | 31 | Q4 2023 | 5.5% |
ESPERION THERAPEUTICS INC | 27 | Q4 2023 | 34.4% |
VIVUS INC | 15 | Q4 2016 | 21.3% |
CELLDEX THERAPEUTICS | 14 | Q2 2020 | 2.7% |
PROSHARES ULTRAPRO SHORT S&P500 | 4 | Q4 2017 | 3.8% |
PROSHARES ULTRASHORT S&P500 | 4 | Q4 2017 | 3.0% |
PROSHARES ULTRASHORT S&P 500 ETF | 3 | Q3 2019 | 0.8% |
View Meditor Group Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
EXELIXIS, INC. | April 09, 2019 | 15,001,073 | 5.0% |
VIVUS INC | December 19, 2012 | 5,002,896 | 5.0% |
VIVUS INC | March 21, 2012 | 6,177,500 | 6.3% |
VION PHARMACEUTICALS INC | February 15, 2008 | 5,736,200 | 7.6% |
CYPRESS BIOSCIENCE INC | September 26, 2007 | 1,864,645 | 5.0% |
ONYX PHARMACEUTICALS INC | September 12, 2007 | 2,627,800 | 4.8% |
ACUSPHERE INC | July 26, 2007 | 1,839,421 | 4.0% |
NOVACEA INC | June 11, 2007 | 800,000 | 3.4% |
ATHEROGENICS INC | May 02, 2007 | 1,361,800 | 3.5% |
View Meditor Group Ltd's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-11 |
13F-HR | 2024-01-04 |
SC 13G/A | 2024-01-03 |
13F-HR | 2023-10-31 |
13F-HR | 2023-07-25 |
13F-HR | 2023-04-10 |
13F-HR | 2023-01-05 |
SC 13G/A | 2023-01-04 |
13F-HR | 2022-11-07 |
13F-HR | 2022-07-18 |
View Meditor Group Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.